drugset / Trial / NCT02936596

Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome

NCT02936596

Unknown 53 enrolled Xiaoli Fan
RandomizedParallel-groupOpen-labelTreatment

Summary

Biochemical response of primary biliary cholangitis-autoimmune hepatitis overlap syndrome induced by ursodeoxycholic acid only or combination therapy of immunosuppressive agents

Timeline

Start
2016-12
Primary completion
2022-06-01
Completion
2022-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Azathioprine Small molecule
Subject Methylprednisolone Other / unclassified
Subject Ursodeoxycholic Acid Small molecule